Abstract
Allogenic bone marrow transplantation is now a major treatment in hematology both for severe aplastic anemia and following intensive chemoradiotherapy regimens for chronic myeloid leukemia, high-risk acute lymphoblastic leukemia, and acute myeloid leukemia. It is also the sole therapy available in some severe combined immunodeficiencies and genetic defects. In the leukemias—with the exception of the graft-versus-leukemia effect, and unlike the other conditions mentioned—the use of marrow transplantation is not therapeutic per se, but simply a method by which high-dose, often curative therapy can be given without regard to marrow toxicity. Applying the same principle to lymphoma and solid tumors has allowed the selection of the most active agents for use in combinations, at doses limited only by extramedullary toxicity. However, the availability of HLA- and DR-matched allograft is limited by the lack of a matched sibling marrow for three-quarters of all patients, and there is a high incidence of lethal graft-versus-host disease in patients aged over 35 years. Other options are to use either autologous grafts or mismatched allografts. At present, autologous bone marrow transplantation (ABMT) is clearly the alternative of choice. ABMT is currently used either to shorten the period of aplasia after nonablative high-dose chemotherapy or as a rescue after massive, presumptively lethal myeloablative chemotherapy, often with total body irradiation (TBI). The successful use of ABMT in adults was first described by McFarland [1] in 1959, and in children by Clifford in 1961 [2].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
McFarland W, Granville NB, Damesheck W (1959) Autologous bone marrow infusion as an adjunct in therapy of malignant disease. Blood 14: 503–521
Clifford P, Clift RA, Duff JK (1961) Nitrogen mustard therapy combined with autologous marrow infusion. Lancet is 687
Thomas ED, Buckner CD, Banaji M (1977) One hundred patients with acute leukemia treated by chemotherapy, total body irradiation and allogeneic marrow transplantation. Blood 49: 511
Pinkerton R, Philip T, Bouffet E, Lashford L, Kemshead J (1986) Autologous bone marrow transplantation in paediatric solid tumours. Clin Haematol 15: 187
Pinkerton R, Philip T, Bouffet E, Lashford L, Kemshead J (1986) Autologous bone marrow transplantation in paediatric solid tumours. Clin Haematol 15: 187
Goldie JH, Coldman AJ (1979) A mathematical model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 63: 1727
Goldie JH, Coldman AJ (1983) Quantitative model for multiple levels of drug resistance in clinical tumors. Cancer Treat Rep 67: 923
Goldie JH, Coldman AJ (1985) Genetic instability in the development of drug resistance. Semin Oncol 12: 222
Norton L, Simon R (1977) Tumor size, sensitivity to therapy and design of treatment schedules. Cancer Treat Rep 61: 1307
Norton L (1985) Implications of kinetic heterogeneity in clincal oncology. Semin Oncol 12: 231
Frei E, Canellos GP (1980) Dose: a critical factor in cancer chemotherapy. Am J Med 69: 585
Brock N, Schneider B (1984) Models in cytostatic chemotherapy. Cancer 54: 1229
Shabel F, Griswold D, Thomas H, Laster R (1984) Increasing the therapeutic response rate to anticancer drugs by applying the basic principles of pharmacology. Cancer 54: 1160
Gehan E (1984) Dose-response relationship in clinical oncology. Cancer 54: 1204
Houghton JA, Cook RL, Lutz PJ, Hougthon PJ (1985) Melphalan: a potential new agent in the treatment for childhood rhabdomyosarcoma. Cancer Treat Rep 69: 91
De Vita V (1986) Dose response is alive and well. J Clin Oncol 4: 1157
Salmon SE, Trent JM (1984) Human tumor cloning, Grune and Stratton, Orlando, p 700
Van Huff D, Clark GM, Weiss G, Marshall M, Buchok JB, Knight W, Lemaistre CF (1986) Use of in vitro dose response effects to select antineoplastics for high dose or regional administration regimens. J Clin Oncol 4: 1827
Djerassi I (1975) High dose methotrexate and citrovorum factor rescue. Background and rationale. Cancer Chemother Rep 6: 3
Duff Y (1985) How much is too much high dose cytosine arabinoside? J Clin Oncol 5: 601
Hayes DM, Cvitkovic E, Golbey R, Schneider E, Helson L, Krakoff R (1977) High dose cis platinum diaminedichloride. Cancer 39: 1372
Appelbaum FR, Buckner CD (1986) Overview of the clinical relevance of autologous bone marrow transplanation. Clin Haematol 1: 1
Eder JP, Antman K, Peters W, Henner WD, Ellias A, Shea T, Schryber S, Andersen J, Come S, Schnipper L, Frei E (1986) HIgh dose combination alkylating agent chemotherapy with autologous bone marrow support for metastatic breast cancer. J Clin Oncol 4: 1592
D’Angio GJ, Evans AE (1983) Cyclic low dose total body irradiation for metastatic neuroblastoma. Int J Radiat Oncol Biol Phys 9: 1961
Pino Y, Torres JL, Bross DS (1982) Risk factors in interstitial penumonitis following allogeneic bone marrow transplantation. Int J Radiat Oncol Biol Phys 8: 1301
Goldstone AH, Souhami RL, Lynch DC (1984) Intensive chemotherapy and autologous bone marrow transplantation for relapsed lymphoma. Exp Hematol 12 [Suppl 151: 137
Hartmann O, Kalifa C, Beaujean F, Patte C, Lemerle J (1985) Treatment of advanced neuro-blastoma with two consecutive high dose chemotherapy regimens and ABMT. In: Evans AE, D’Angio GJ, Seeger RC (eds) Advances in Neuroblastoma research. Alan R. Liss, New York, p 565
Hartmann O, Oberlin O, Lemerle J (1984) Acute leukaemia in two patients treated with high dose melphalan and autologous marrow transplantation for malignant solid tumours. J Clin Oncol 2: 1424
Philip T, Biron P, Maraninchi D, Goldstone AH, Hervé P, Souillet G, Gastaut JL, Plouvier E, Flesh Y, Philip I, Harousseau JL, Le Mevel A, Rebattu P, Linch DC, Freycon F, Milan JJ, Souhami RL (1985) Massive chemotherapy with ABMT in 50 cases of bad prognosis non Hodgkin’s lymphoma. Br J Haematol 60: 599
Philip T, Bernard JL, Zucker JM, Souillet G, Favrot MC, Philip I, Bordigoni P, Lutz JP, Plouvier E, Carton P, Robert A, Kemshead J (1985) Purging autologous bone marrow transplantation in 25 cases of advanced neuroblastoma. Lancet ii: 576
Rebattu P, Philip T, Maraninchi D, Hartmann O, Cahn JY, Bordigoni P, Colombat JP, Le Mevel A, Laporte JP, Biron P (1985) Indications et résultats de l’autogreffe de moelle dans les lymphomes malins non Hodgkiniens (étude de 92 cas). Nouv Rev Fr Hématol 27 [Suppl 2]: 252
Appelbaum FR, Sullivan KM, Thomas ED, Buckner CD, Clift RA, Deeg HJ, Fefer A, Hill R, Sanders J, Steward P, Storb R (1985) Marrow transplantation as treatment for patients with recurrent malignant lymphoma. Int J Cell Cloning 4: 216
Singer CR, Goldstone AH (1986) Non Hodgkin’s lymphomas. Clin Haematol 15: 105
Goldstone AH (1985) Autologous bone marrow transplantation for non Hodgkin’s lymphoma. In: Dicke KA, Spitzer G, Zander AR (eds) Autologous bone marrow transplantation. Proceedings of the 1st international symposium. University of Texas M.D. Anderson Hospital and Tumor Institute Houston, p 67
Philip T, Hartmann O, Pinkerton R, Patte C, Biron P, Souillet G, Bernard JL, Freycon F, Bordigoni P, Laporte JP, Marguerite G, Le Mevel A, Plouvier E, Favrot MC, Philip I, Lemerle J (1985) Massive chemotherapy with autologous bone marrow transplantation in Burkitt’s lymphoma (a review of 50 patients treated in France). Blood Transfus Immunohaematol 5: 521
Armitage JO, Gingrich RD, Foley JF, Kessinger MA, Klassen LW, Kumar PO, Tempero MA, Vaughan WP (1985) which patients with lymphoma can be salvaged with high-dose cytoreduction and autologous marrow rescue? In: Dicke KA, Spitzer G. Zander AR (eds) Autologous bone marrow transplantation Proceedings of the 1st international symposium. University of Texas M.D. Anderson Hospital and Tumor Institute Houston, p 57
Philip T, Armitage JO, Spitzer G, Chauvin F, Jagannath S, Cahn JY, Colombat P, Goldstone AH, Gorin NC, Flesh M, Laporte JP, Maraninchi D, Pico JL, Bosly A, Anderson C, Shots R, Biron P, Cabanillas F, Dicke K (1987) High dose therapy and ABMT in 100 adults with intermediate or high grade non Hodgkin’s lymphoma. N Engl J Med 316: 1493–1497
Cabanillas F, Hagemeister FB, Bodey GP, Freireich EJ (1982) IMVP-16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapy. Blood 60: 693
Cabanillas F, Hagemeister FB, McLaughlin P, Salvador P, Velasquez WS, Riggs S, Freireich EJ (1984) Mime combination chemotherapy or refractory or recurrent lymphomas. Proc Ame Soc Clin Oncol 3: 250
Cabanillas F, Hagemeister FB, Bodey GP (1984) M.D. Anderson experience with VP16 for therapy of refractory or recurrent lymphoma. In: Issel BF, Muggia FM, Carter SK (eds) Etoposide (VP-16): current status and new developments. Academic Press, New York, p 313
Cabanillas F, Hagemeister FB, Riggs S, Salvador P, Velasquez WS, McLaughlin P, Smith T (1985) Results of ifosfamide-etoposide combinations for patients with recurrent or refractory aggressive lymphoma. In: Cavalli F (ed) Malignant lymphomas and Hodgkin’s disease: experimental and therapeutic advances. Martinus Nijhoff, Boston, p 485
Philip T, Armitage J, Spitzer G, Cabanillas F, Velasquez W, Hagenbeck T, Jagannath S (1988) Background for an international randomized study on relapsed diffuse intermediate and high grade lymphoma in adults. In: Dicke K, Spitzer G, Jagannath S (eds) Proceedings of the 3rd International symposium on autologous bone marrow transplantation. Houston, pp 313–333
Phillips GL (1983) Current clinical trial with intensive therapy and autologous bone marrow transplantation for lymphomas and solid tumors. In: Gale RP (ed) Recent advances in bone marrow transplantation. UCLA symposia new series, vol 7. Alan R. Liss, New York, p 43
Phillips GL, Herzig RH, Lazarus HM, Fay JW, Wolff SN, Mill WB, Lin H, Thomas PRM, Glasgow GP, Shina DC, Herzig GP (1984) Treatment of resistant malignant lymphoma with cyclophosphamide total body irradiation and transplantation of cryopreserved autologous marrow. N Engl J Med 31: 1557
Philip T, Biron P, Philip I, Frappaz D, Pinkerton R, Souillet G, Bernard JL, Laporte JP, Philippe N, De Terlizzi M, Demeocq F, Dufillot JF, Kremens B, Bonetti F, Favrot MC (1988) Autologous bone marrow transplantation in Burkitt’s lymphoma (50 cases in the Lyon protocol). In: Dicke K, Spitzer G, Jagannath S (eds) 3rd international symposium on autologous bone marrow transplantation. Houston, pp 249–261
Santos GW, Tutschka PJ, Brookmeyer R (1983) Marrow transplantation for acute non lym-phocytic leukemia after treatment with busulfan and cyclophosphamide. N Engl J Med 309: 1347
Philip T, Pinkerton R, Hartmann O, Patte C, Philip I, Biron P, Favrot MC (1986) The role of massive therapy with autologous bone marrow transplantation in Burkitt’s lymphoma. Clin Haematol 15: 205
Canellos P (1985) Bone marrow transplantation as salvage therapy in advanced Hodgkin disease: allogenic or autologous? J Clin Oncol 11: 1451
Phillips GL, Reece DE (1986) Clinical studies of autologous bone marrow transplantation in Hodgkin’s disease. Clin Haematol 15: 151
Spitzer G, Dicke KA, Litam J, Verma DS, Zander AR, Lanzotti V, Valdivieso M, McCredie KB, Samules ML (1980) High dose combination chemotherapy with autologous bone marrow transplantation in adult solid tumors. Cancer 45: 3075
Carella AM, Santini G, Girodano D, Frassoni F, Nati S, Congiu A, Occhini D, Rossi E, Martinengo M, Damasio E, Lercari G, Marmont AM (1984) High dose chemotherapy and non-frozen ABMT in resistant or relapsed malignant lymphomas. Cancer 54: 2836
Hryniuk W (1986) Is more better? J Clin Oncol 5: 621
Hryniuk W (1986) Is more better? J Clin Oncol 5: 621
Philip T, Hervé P, Racadot E (1982) Intensive cytoreductive regimen and autologous bone marrow transplantation in leukaemias and solid tumours (a review). Transplant Clin Immunol 14: 86
Philip T (1985) Chimiothérapie massive et autogreffe de moelle dans les tumeurs des parties molles (15 cas). Bull Cancer (Paris) 72: 62
Cornbleet M, Corringham R, Prentice H, Boesen E, McElwain TJ (1981) Treatment of Ewing sarcoma with high dose melphalan and autologous bone marrow transplantation. Cancer Treat Rep 63: 241
Philip T (1984) Status of the role of ABMT in solid tumours in Europe. Proceedings of the European Bone Marrow Transplant Group, Granada, 1984
Biron P, Philip T, Maraninchi D (1985) Massive chemotherapy and ABMT in progressive disease of non-seminomatous testicular cancer. In: Dicke K, Spitzer G, Zander AR (eds) Autologous bone marrow transplantation. University of Texas, M.D. Anderson Hospital and Tumor Institute Houston, p 203
Baumgartner C, Bleher EA, Brun Del Re G (1984) Autologous bone marrow transplantation in the treatment of children and adolescents with advanced malignant tumors. Med Pediatr Oncol 12: 104
Ekert H, Ellis WM, Waters KD, Tauro GP (1982) Autologous bone marrow rescue in the treatment of advanced tumours of childhood. Cancer 49: 603
Philip T, Zucker JM, Bernard JL, Biron P, Kremens B, Quintana E, Gentet JC, Bordigoni P, Frappaz D, Souillet G, Philip I, Chauvin F, Favrot MC (1987) Bone marrow transplantation in an unselected group of 65 stage IV neuroblastoma patients. In: Dicke K, Spitzer G, Jagannath S (eds) Proceedings of the 3rd international symposium on autologous bone marrow transplantation. Houston, pp 407–417
Hartmann 0 (1987) Institut Gustave Roussy experience in neuroblastoma. In: Dicke K, Spitzer G, Jagannath S (eds) Proceedings of the 3rd international autologous bone marrow transplantation. Houston
Seeger B (1987) The UCLA experience in neuroblastoma. In: Dicke K, Spitzer G, Jagannath S (eds) Proceedings of the 3rd international symposium on autologous bone marrow transplantation. Houston
August CA (1987) The Philadelphia experience in neuroblastoma. In: Dicke K, Spitzer G, Jagannath S (eds) Proceedings of the 3rd international symposium on autologous bone marrow transplantation. Houston
Pinkerton R (1987) The ENSG experience in neuroblastoma. In: Dicke K, Spitzer G, Jagannath S (eds) Proceedings of the 3rd International symposium on autologous bone marrow transplantation. Houston, pp 401–405
Deacon JM, Wilson PA, Peckham MJ (1985) The radiobiology of human neuroblastoma. Radiother Oncol 3: 201
Hartmann O, Benhamou E, Beaujean F, Pico JL, Kalifa C, Patte C, flamant F, Lemerle J (1986) High dose busulfan and cyclophosphamide with autologous bone marrow transplantation support in advanced malignancies in children: a phase II study. J Clin Oncol 4: 1804
Antman K, Eder JP, Elias A, Shea T, Peters WP, Andersen J, Schryber S, Henner WD, Finberg R, Wilmore D, Kaplan W, Lew M, Kruskall MS, Anderson K, Gorgone B, Bast R, Schnipper L, Frei E (1987) A high dose combination alkylating agent preparative regimen with autologous bone marrow support: the DFCI/BIN experience. Cancer Treat Rep 71: 19–25
Humblet Y, Symann M, Bosly A, Delaunois L, Francis C, Machiels J, Beauduin M, Doyen C, Prignot J (1987) Transplantation in selected small cell carcinoma of the lung: a randomized study. J Clin Oncol 12: 1921–1930
Farha P, Spitzer G, Valdivieso M (1983) High dose chemotherapy and autologous bone marrow transplantation for the treatment of small cell lung carcinoma. Cancer 52: 1351
Souhami RL, Harper PG, Linch D (1983) High dose cyclophosphamide with autologous marrow support for treatment of small cell carcinoma of the bronchus. Cancer Chemother Pharmacol 10: 205
Spitzer G, Dicke K, Zander AR, Farha P, Valdivieso M (1986) High dose intensification therapy with autologous bone marrow support for limited small cell bronchogenic carcinoma. J Clin Oncol 4: 4
Lazarus H, Herzig R, Wolff S (1985) Treatment of metastatic malignant melanoma with intensive melphalan and autologous bone marrow transplantation. Cancer Treat Rep 69: 473
Cornbleet MA, McElwain TJ, Kumar RI (1983) Treatment of advanced malignant melanoma with high dose melphalan and autologous bone marrow transplantation. Br J Cancer 48: 329
Tchekmedyian JS, Tait N, Van Echo D, Aisner J (1986) High dose chemotherapy without bone marrow transplantation in melanoma. J Clin Oncol 4: 1811
Blijham G, Spitzer G, Litam J (1981) The treatment of advanced testicular carcinoma with high dose chemotherapy and autologous marrow support. Eur J Cancer 17: 443
Champlin R (1985) Autologous bone marrow transplantation of testicular carcinoma. Int J Cell Cloning 3: 260
Wolff S (1983) Intensive VP16–213 chemotherapy for advanced refractory germinal cell tumors. J Cell Biol [Suppl] 2: 125
Stewart P (1982) Autologous bone marrow transplantation in metastatic breast cancer. Breast Cancer Res Treat 2: 85
Gisselbrecht J (1986) The St Louis experience with ABMT in breast carcinoma. European Organisation for Research and Treatment of Cancer Meeting, Bruxelles, 1986
Hildebrand J, Badjou R, Collard-Ronge E (1980) Treatment of brain gliomas with high dose of CCNU and autologous bone marrow transplantation. Biomedicine 32: 71
Takvorian T, Parker LM, Hockberg FH (1983) Autologous bone marrow transplantation: host effects of high dose BCNU. J Clin Oncol 1: 610
Phillips G, Fay J, Herzig G (1985) Autologous bone marrow transplantation in malignant glioma. Int J Cell Cloning 3: 257
Phillips GL, Wolff SN, Fay JW, Herzig RH, Lazarus HM, Schold C, Herzing GP (1986) Intensive 1, 3, bis-(2 chloroethyl)1-nitrosourea (BCNU) monochemotherapy and autologous marrow transplantation for malignant glioma. J Clin Oncol 4: 639
Phillips GL, Wolff SN, Fay JW, Herzig RH, Lazarus HM, Schold C, Herzing GP (1986) Intensive 1, 3, bis-(2 chloroethyl)1-nitrosourea (BCNU) monochemotherapy and autologous marrow transplantation for malignant glioma. J Clin Oncol 4: 639
Biron P, Mornex F, Vial C, Chauvin F, Veyssere M, Philip I, Philip T (1987) Pilot study of high dose carmustine, transplantation, radiotherapy and surgery for patients with glioma. In: Dicke K, Spitzer G, Jagannath S (eds) Proceeding of the 3rd international symposium on autologous bone marrow transplantation. Houston
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Philip, T., Pinkerton, R. (1989). Very High Dose Therapy in Lymphomas and Solid Tumors. In: Magrath, I. (eds) New Directions in Cancer Treatment. UICC International Union Against Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83405-9_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-83405-9_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-19063-9
Online ISBN: 978-3-642-83405-9
eBook Packages: Springer Book Archive